» Articles » PMID: 35769384

The Structure Basis of Phytochemicals As Metabolic Signals for Combating Obesity

Overview
Journal Front Nutr
Date 2022 Jun 30
PMID 35769384
Authors
Affiliations
Soon will be listed here.
Abstract

The consumption of phytochemicals, bioactive compounds in fruits and vegetables, has been demonstrated to ameliorate obesity and related metabolic symptoms by regulating specific metabolic pathways. This review summarizes the progress made in our understanding of the potential of phytochemicals as metabolic signals: we discuss herein selected molecular mechanisms which are involved in the occurrence of obesity that may be regulated by phytochemicals. The focus of our review highlights the regulation of transcription factors toll like receptor 4 (TLR4), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the peroxisome proliferator-activated receptors (PPARs), fat mass and obesity-associated protein (FTO) and regulation of microRNAs (miRNA). In this review, the effect of phytochemicals on signaling pathways involved in obesity were discussed on the basis of their chemical structure, suggesting molecular mechanisms for how phytochemicals may impact these signaling pathways. For example, compounds with an isothiocyanate group or an α, β-unsaturated carbonyl group may interact with the TLR4 signaling pathway. Regarding Nrf2, we examine compounds possessing an α, β-unsaturated carbonyl group which binds covalently with the cysteine thiols of Keap1. Additionally, phytochemical activation of PPARs, FTO and miRNAs were summarized. This information may be of value to better understand how specific phytochemicals interact with specific signaling pathways and help guide the development of new drugs to combat obesity and related metabolic diseases.

Citing Articles

Ellagic Acid Modulates Necroptosis, Autophagy, Inflammations, and Stress to Ameliorate Nonalcoholic Liver Fatty Disease in a Rat Model.

Li Z, Li J, He S, Chen J, Deng C, Duan J Food Sci Nutr. 2025; 13(1):e4694.

PMID: 39830906 PMC: 11742184. DOI: 10.1002/fsn3.4694.


New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors.

Marchese E, Gallo Cantafio M, Ambrosio F, Torcasio R, Valentino I, Trapasso F Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139838 PMC: 10747119. DOI: 10.3390/ph16121712.


Immunomodulation by cannabidiol in bovine primary ruminal epithelial cells.

Kent-Dennis C, Klotz J BMC Vet Res. 2023; 19(1):208.

PMID: 37845710 PMC: 10577946. DOI: 10.1186/s12917-023-03756-4.


Association of Plant-Based and High-Protein Diets with a Lower Obesity Risk Defined by Fat Mass in Middle-Aged and Elderly Persons with a High Genetic Risk of Obesity.

Daily J, Park S Nutrients. 2023; 15(4).

PMID: 36839421 PMC: 9960655. DOI: 10.3390/nu15041063.


A New Frontier in Studying Dietary Phytochemicals in Cancer and in Health: Metabolic and Epigenetic Reprogramming.

Shannar A, Sarwar M, Kong A Prev Nutr Food Sci. 2023; 27(4):335-346.

PMID: 36721757 PMC: 9843711. DOI: 10.3746/pnf.2022.27.4.335.

References
1.
Huang L, Zhang J, Zhu X, Mi X, Li Q, Gao J . The Phytochemical Rhein Mediates MA-Independent Suppression of Adipocyte Differentiation. Front Nutr. 2021; 8:756803. PMC: 8592053. DOI: 10.3389/fnut.2021.756803. View

2.
Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

3.
Bruning J, Chalmers M, Prasad S, Busby S, Kamenecka T, He Y . Partial agonists activate PPARgamma using a helix 12 independent mechanism. Structure. 2007; 15(10):1258-71. DOI: 10.1016/j.str.2007.07.014. View

4.
Chen X, Acquaah-Mensah G, Denning K, Peterson J, Wang K, Denvir J . High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. Am J Physiol Gastrointest Liver Physiol. 2020; 319(5):G626-G635. PMC: 8087345. DOI: 10.1152/ajpgi.00213.2020. View

5.
Shi L, Hao Z, Zhang S, Wei M, Lu B, Wang Z . Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC. Biochem Pharmacol. 2018; 150:9-23. DOI: 10.1016/j.bcp.2018.01.026. View